Dose Defining Study for the Administration of Vitamin K2 Supplements in Hemodialysis Patients

NCT ID: NCT01675206 Phase: PHASE3 Status: COMPLETED Enrollment: 165 Completion: 2012-04

Conditions

Vascular Calcification

Interventions

Vitamin K2 supplementation

Summary

This study aims at finding the optimal dose of Vitamin K2 supplementation in hemodialysis patients.

Primary Outcome

percentage of reduction in dp-ucMGP after 8 weeks of Vitamin K2 supplementation

Source

ClinicalTrials.gov